Cationic antimicrobial peptides – an update

Bibliography

• BOMAN HG: Peptide antibiotics: holy or heretic grails of innate immunity? Scand. I Immunol (1996) 43:475–482.
   Web of Science ®Google Scholar
• GANZ T, LEHRER RI: Antimicrobial peptides of leukocytes. Carr: Opin. Hematol (1997) 4:53–58.
   PubMedGoogle Scholar
• GANZ T, WEISS J: Antimicrobial peptides of phagocytes and epithelia. Semin. Hematol (1997) 34:343–354.
   PubMed Web of Science ®Google Scholar
• BULOW E, BENGTSSON N, CALAF AJ, GULLBERG U, OLSSON I: Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells. J. Leukoc. Biol. (2002) 72:147–153.
   PubMed Web of Science ®Google Scholar
• SORENSEN OE, FOLLIN P, JOHNSEN AH et al: Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood (2001) 97:3951–3959.
   PubMed Web of Science ®Google Scholar
• HANCOCK RE: Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. (2001) 1:156–164.
   PubMedGoogle Scholar
• TANG YQ, YUAN J, OSAPAY G et al.: Acyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated a-defensins. Science (1999) 286:498–502.
   PubMed Web of Science ®Google Scholar
• HENZLER WILDMAN KA, LEE DK, RAMAMOORTHY A: Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry (Mosc) (2003) 42:6545–6558.
   Google Scholar
• HALLOCK KJ, LEE DK, RAMAMOORTHY A: MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys. J. (2003) 84:3052–3060.
   PubMed Web of Science ®Google Scholar
• SHAI Y: Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta (1999) 1462:55-70. II. WU M, MAIER E, BENZ R, HANCOCK RE: Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coil Biochemistry (Mosc) (1999) 38:7235–7242.
   Google Scholar
• GENNARO R, ZANETTI M, BENINCASA M, PODDA E, MIANI M: Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Carr. Pharm. Des. (2002) 8:763–778.
   PubMed Web of Science ®Google Scholar
• BERA A, SINGH S, NAGARAJ R, VAIDYA T: Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Ma Biochem. Parasitol (2003) 127:23–35.
   PubMed Web of Science ®Google Scholar
• HONG RW, SHCHEPETOV M, WEISER JN, AXELSEN PH: Transcriptional profile of the Escherichia coil response to the antimicrobial insect peptide cecropin A. Antimicrob. Agents Chemother. (2003) 47:1–6.
   PubMed Web of Science ®Google Scholar
• YANG D, CHERTOV 0, OPPENHEIM JJ: The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell. MM. Life ScL (2001) 58:978–989.
   PubMed Web of Science ®Google Scholar
• •This is a thorough review on the multiple effectors of innate immunity peptides in both innate defence and adaptive immunity. Topics covered include the role of such peptides and their function in concert with enzymes, complement factors, chemokines and receptors to contend with microorganisms.
   Google Scholar
• GANZ T: Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol (2003) 3:710–720.
   PubMed Web of Science ®Google Scholar
• NIYONSABA F, HIRATA M, OGAWA H, NAGAOKA I: Epithelial cell-derived antibacterial peptides human I3-defensins and cathelicidin: multifunctional activities on mast cells. Can: Drug Targets Inflamm. Allergy (2003) 2:224–231.
   Google Scholar
• DORSCHNER RA, PESTONJAMASP VK, TAMAKUWALA S et al.: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol (2001) 117:91–97.
   PubMed Web of Science ®Google Scholar
• WOO JS, JEONG JY, HWANG YJ et al.: Expression of cathelicidin in human salivary glands. Arch. Otolaryngol Head Neck Surg. (2003) 129:211–214.
   PubMed Web of Science ®Google Scholar
• KIM ST, CHA HE, KIM DY et al: Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol (2003) 123:81–85.
   PubMed Web of Science ®Google Scholar
• BALS R: Epithelial antimicrobial peptides in host defense against infection. Respir. Res. (2000) 1:141–150.
   PubMedGoogle Scholar
• SEO SJ, AHN SW, HONG CK, RO BI: Expressions of I3-defensins in human keratinocyte cell lines. J. Dermatol Sci. (2001) 27:183–191.
   PubMed Web of Science ®Google Scholar
• TOLLIN M, BERGMAN P, SVENBERG T et al.: Antimicrobial peptides in the first line defence of human colon mucosa. Peptides (2003) 24:523–530.
   PubMed Web of Science ®Google Scholar
• SALZMAN NH, GHOSH D, HUTTNER KM, PATERSON Y, BEVINS CL: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 422:522–526.
   PubMed Web of Science ®Google Scholar
• ONG PY, OHTAKE T, BRANDT C et al.:Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl. J. Med. (2002) 347:1151–1160.
   PubMed Web of Science ®Google Scholar
• FELLERMANN K, WEHKAMP J, STANGE EF: Antimicrobial peptides in the skin. N Engl. J. Med. (2003) 348:361-363; author reply: 361–363.
   Google Scholar
• PUTSEP K, CARLSSON G, BOMAN HG, ANDERSSON M: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet (2002) 360:1144–1149.
   PubMed Web of Science ®Google Scholar
• TAGGART CC, GREENE CM, SMITH SG et al.: Inactivation of human P-defensins 2 and 3 by elastolytic cathepsins. Immunol (2003) 171:931–937.
   Web of Science ®Google Scholar
• WEINER DJ, BUCKI R, JANMEY PA: The antimicrobial activity of the cathelicidin LL-37 is inhibited by F-actin bundles and restored by gelsolin. Am. J. Respir. Cell Ma Biol. (2003) 28:738–745.
   PubMed Web of Science ®Google Scholar
• WEHKAMP J, HARDER J, WEICHENTHAL M et al: Inducible and constitutive I3-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. (2003) 9:215–223.
   PubMed Web of Science ®Google Scholar
• FOLWACZNY C, GLAS J, TOROK HP:Crohn's disease: an immunodeficiency? Lim Castroenterol Hepatol (2003) 15:621–626.
   Google Scholar
• PARK CH, VALORE EV, WARING AJ, GANZ T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Biol. Chem. (2001) 276:7806–7810.
   Web of Science ®Google Scholar
• NICOLAS G, VIATTE L, BENNOUN M et al.: Hepcidin, a new iron regulatory peptide. Blood Cells Ma Dis. (2002) 29:327–335.
   PubMed Web of Science ®Google Scholar
• NICOLAS G, BENNOUN M, PORTEU A et al.: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA (2002) 99:4596–4601.
   PubMed Web of Science ®Google Scholar
• WEINSTEIN DA, ROY CN, FLEMING MD et al: Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 100:3776–3781.
   PubMed Web of Science ®Google Scholar
• •This review highlights the multiple roles of innate peptides as mediators of inflammation with an impact on epithelial and inflammatory cells, and their influence on diverse processes such as cell proliferation, immune induction, wound healing, cytokine release, chemotaxis and protease-antiprotease balance.
   Google Scholar
• KOCZULLA AR, BALS R: Antimicrobial peptides: current status and therapeutic potential. Drugs (2003) 63:389–406.
   PubMed Web of Science ®Google Scholar
• SCOTT MG, DAVIDSON DJ, GOLD MR, BOWDISH D, HANCOCK RE: The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. Immunol. (2002) 169:3883–3891.
   Web of Science ®Google Scholar
• NAGAOKA I, HIROTA S, NIYONSABA F et al.: Catheficidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-a by blocking the binding of LPS to CD14(±) cells. Immunol. (2001) 167:3329–3338.
   Web of Science ®Google Scholar
• NIYONSABA F, SOMEYA A, HIRATA M, OGAWA H, NAGAOKA I: Evaluation of the effects of peptide antibiotics human defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Ear: Immunol. (2001) 31:1066–1075.
   PubMed Web of Science ®Google Scholar
• AARBIOU J, ERTMANN M, VAN WETERING S et al.: Human neutrophil defensins induce lung epithelial cell proliferation M vitro. I Leukoc. Biol. (2002) 72:167–174.
   Google Scholar
• AARBIOU J, VERHOOSEL VAN WETERING S et al.: Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression M vitro Am.Respir. Cell Mol. Biol. (2003)30(2):193–201.
   Google Scholar
• HEILBORN JD, NILSSON ME KRATZ G et al.: The catheficidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. Invest. Dermatol. (2003) 120:379–389.
   Google Scholar
• KOCZULLA R, VON DEGENFELD G, KUPATT C et al.: An angiogenic role for the human peptide antibiotic LL-37 hCAP-18. j Clin. Invest. (2003) 111:1665–1672.
   PubMed Web of Science ®Google Scholar
• •This paper provides direct in vivo evidence for the key role of LL-37 in angiogenesis and wound repair.
   Google Scholar
• WEISS J, ELSBACH P, OLSSON I, ODEBERG H: Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. Biol. Chem. (1978) 253:2664–2672.
   Web of Science ®Google Scholar
• LEVY 0: Antibiotic proteins of polymorphonuclear leukocytes. Ear: Haematol. (1996) 56:263–277.
   PubMed Web of Science ®Google Scholar
• WAKABAYASHI H, TAKASE M, TOMITA M: Lactoferricin derived from milk protein lactoferrin. Curr: Pharm. Des. (2003) 9:1277–1287.
   PubMed Web of Science ®Google Scholar
• HARDER J, SCHRODER JM: RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin.' Biol. Chem. (2002) 277:46779–46784.
   Web of Science ®Google Scholar
• TANG YQ, YEAMAN MR, SELSTED ME: Antimicrobial peptides from human platelets. Infect. Immun. (2002) 70:6524–6533.
   PubMed Web of Science ®Google Scholar
• •Chemokines recruit and activate leukocytes, and cationic antimicrobial peptides inactivate invading bacterial, fungal or viral pathogens. This article provides new important evidence showing that the two classes of mediators have many features in common as well as demonstrating that antimicrobial activity can be exerted by platelet chemokines, thereby contributing to innate defence.
   Google Scholar
• STARNER TD, BARKER CK, JIA HP, KANG Y, MCCRAY PB: CCL20 is an inducible product of human airway epithelia with innate immune properties. Am. .1 Respir. Cell Mol. Biol. (2003) 29(5):627–633.
   Google Scholar
• ALLAKER RP, KAPAS S: Adrenomedullin expression by gastric epithelial cells in response to infection. Clin. Diagn. Lab. Immunol. (2003) 10:546–551.
   PubMedGoogle Scholar
• ALLAKER RP, KAPAS S: Adrenomedullin and mucosal defence: interaction between host and microorganism. Regul. Pept. (2003) 112:147–152.
   PubMed Web of Science ®Google Scholar
• LIEPKE C, BAXMANN S, HEINE C et al.: Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides. I Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2003) 791:345–356.
   PubMed Web of Science ®Google Scholar
• CHALEKSON CP, NEUMEISTER MW, JAYNES J: Treatment of infected wounds with the antimicrobial peptide D2A21. Trauma (2003) 54:770–774.
   PubMed Web of Science ®Google Scholar
• CHALEKSON CP, NEUMEISTER MW, JAYNES J: Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel). Plast. Reconsm Surg. (2002) 109:1338–1343.
   PubMed Web of Science ®Google Scholar
• ROTHSTEIN DM, SPACCIAPOLI P, TRAN LT et Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob. Agents Chemother. (2001) 45:1367–1373.
   PubMed Web of Science ®Google Scholar
• DIMARCQ JL, HUNNEYBALL I: Pharma-entomology: when bugs become drugs. Drug Discov. Today (2003) 8:107–110.
   PubMed Web of Science ®Google Scholar
• LAMBERTY M, CAILLE A, LAND ON Cet al.: Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities. Biochemistry (Mose) (2001) 40:11995–12003.
   Google Scholar
• ZASLOFF M: Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA (1987) 84:5449–5453.
   PubMed Web of Science ®Google Scholar
• KOKRYAKOV VN, HARWIG SS, PANYUTICH EA et al.: Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. (1993) 327:231–236.
   PubMed Web of Science ®Google Scholar
• MOSCA DA, HURST MA, SOW et al.:IB-367, a protegrin peptide with M vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob. Agents Chemother. (2000) 44:1803–1808.
   PubMed Web of Science ®Google Scholar
• SELSTED ME, NOVOTNY MJ, MORRIS WL et al.: Indoficidin, a novel bactericidal tridecapeptide amide from neutrophils. I Biol. Chem. (1992) 267:4292–4295.
   Web of Science ®Google Scholar
• SIMON A, FLEISCHHACK G, MARKLEIN G, RITTER J: [Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients]. KIM. Padiatr. (2001) 213\(Suppl. 1):A22–A37.
   Google Scholar
• EL-SAYED S, NABID A, SHELLEY W et al.: Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind,
   Google Scholar